Trafalgar International (GCAN) Cash from Operations (2017 - 2026)
Trafalgar International (GCAN) posted Cash from Operations of -$4376.0 for Q1 2026, up 81.87% on a QoQ basis from -$24140.0 in Q4 2025, and up 60.77% year-over-year from -$2721.9 in Q1 2025.
Powered by 
Analysis
Trafalgar International (GCAN) Cash from Operations (2017 - 2026) Analysis & Trends
Trafalgar International has reported Cash from Operations for 10 years, with the latest figure at -$4376.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 60.77% year-over-year to -$4376.0 in Q1 2026; TTM through Mar 2026 was -$53374.0, a 35.78% increase from a year earlier, with the FY2025 full-year figure at -$60153.0, up 45.06% from the prior year.
- Cash from Operations was -$4376.0 for Q1 2026 at Trafalgar International, up from -$24140.0 in the prior quarter.
- The five-year high for Cash from Operations was -$4376.0 in Q1 2026, with the low at -$56392.0 in Q2 2022.
- Average Cash from Operations over 5 years is -$22628.3, with a median of -$19064.0 recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations surged 84.96% in 2024, then tumbled 391.25% in 2025.
- Over 5 years, Cash from Operations stood at -$19064.0 in 2022, then slumped by 71.39% to -$32673.0 in 2023, then soared by 84.96% to -$4914.0 in 2024, then slumped by 391.25% to -$24140.0 in 2025, then jumped by 81.87% to -$4376.0 in 2026.
- The last three Cash from Operations figures came in at -$4376.0 (Q1 2026), -$24140.0 (Q4 2025), and -$5357.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 835.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 3.44 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -387.32 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 507.66 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 313.60 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | -4,376.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -4,376.00 |
| Dec 31, 2025 | -24,140.00 |
| Sep 30, 2025 | -5,357.00 |
| Jun 30, 2025 | -19,501.00 |
| Mar 31, 2025 | -11,155.00 |
| Dec 31, 2024 | -4,914.00 |
| Sep 30, 2024 | -18,034.00 |
| Jun 30, 2024 | -49,007.00 |
| Mar 31, 2024 | -37,536.00 |
| Dec 31, 2023 | -32,673.00 |
| Sep 30, 2023 | -41,215.00 |
| Jun 30, 2023 | -10,806.00 |
| Mar 31, 2023 | -18,477.00 |
| Dec 31, 2022 | -19,064.00 |
| Sep 30, 2022 | -22,103.00 |
| Jun 30, 2022 | -56,392.00 |
| Mar 31, 2022 | -9,931.00 |
| Dec 31, 2021 | -78,838.00 |
| Sep 30, 2021 | -72,572.00 |
| Jun 30, 2021 | -37,792.00 |